Theravance Biopharma Inc (TBPH)

Total Costs & Expenses

$99.66M

TTM · Period ending: · USD

TBPH logo

TBPH Total Costs & Expenses

Latest reported$99.66M
TBPH TTM Total Costs & Expenses ($156.51M → $99.66M)
High-resolution chart · PNG

TBPH total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Theravance Biopharma Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
99,655,000
107,240,000
113,513,000
113,141,000
114,401,000
115,442,000
111,330,000
107,181,000
103,929,000
103,840,000
113,459,000
121,734,000
123,934,000
128,213,000
143,303,000
182,336,000
222,492,000
265,365,000
313,095,000
337,202,000
365,265,000
375,425,000
369,614,000
374,465,000
357,221,000
338,663,000
325,329,000
303,616,000
301,276,000
304,830,000
299,121,000
304,454,000
290,438,000
286,888,000
275,509,000
255,343,000
246,640,000
230,978,000
229,114,000
225,256,000
226,480,000
225,939,000
224,025,000
231,544,000
234,149,000
241,402,000
244,227,000
221,296,000
206,000,000
185,277,000
156,510,000
280,203,000
206,506,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.